Transurethral resection and sequential chemo-immunoprophylaxis in primary T163 bladder cancer

European Urology

Volumn 37, Issue 4, 2000, Pages 478-483

  Bono, Aldo V ^a   Lovisolo, Jon A ^a   Saredi, Giovanni ^a  

^a OSPEDALE DI CIRCOLO   (Italy)

Author keywords

Prognosis; T1G3 bladder cancer; Treatment

Indexed keywords

AMINOTRANSFERASE; BCG VACCINE; CYTOTOXIC AGENT; EPIRUBICIN;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLADDER CANCER; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHEMICAL CYSTITIS; CLINICAL TRIAL; CYSTECTOMY; CYSTOSCOPY; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FEVER; FOLLOW UP; HEMATURIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RECURRENT CANCER; SIDE EFFECT; URINE CYTOLOGY;

EID: 0034017396     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1159/000020171     Document Type: Article

References (2)